Navigation Links
California State Senator Shelia Kuehl's Leadership in Stem Cell Debate Praised and 'Embryonic Stem Cell Profiteers' Criticized by Repair Stem Cell Institute Spokesman
Date:10/8/2008

BANGKOK, Thailand, Oct. 8 /PRNewswire/ -- "California State Senator Shelia Kuehl's leadership role in Senate Bill (SB) 1565 is strong action by a prominent Democrat to bring 'adult stem cell' research to the California Institute of Regenerative Medicine (CIRM) as the viable and credible life science that it is," stated Don Margolis, Chairman of The Repair Stem Cell Institute (RSCI; http://www.RepairStemCells.org), a public service company devoted to educating the public about adult stem cell research and treatments worldwide.

"Adult stem cells are now the 'gold standard' and the only stem cells which have any chance to help people in the next decade," declared Margolis. "But embryonic profiteers and their biotech lobby have politically influenced CIRM, creating a taxpayer-funded embryonic stem cell corporate 'welfare' program that hasn't produced even one possible medical treatment. In fact, because they have no viable path to any embryonic stem cell cures, CIRM has already thrown away $271 million of its $3 billion fund to help finance construction of expensive biotech research facilities for the very institutions which have failed to find a way to implant embryonic cells into humans, or even animals for that matter. And now Governor Arnold Schwarzenegger has vetoed Senator Kuehl's legislation which may have led to adult stem cell research, thus delaying access to long-proven safe and effective therapies for people suffering with 100+ diseases."

According to Margolis, "The only good news out of this situation is that a Democratic leader from the largest state in the union has stood up to the powerful embryonic stem cell lobby and taken a valiant stand for citizens. Senator Kuehl must have done her research about adult stem cells. She may have checked the U.S. Government website (http://www.clinicaltrials.gov) and found for herself a list of over 2000 clinical trials, most of which are already implanting adult stem cells into humans for specific diseases such as cancer, heart, diabetes and others. She most likely saw that embryonic stem cell clinical trials are in the single digits with no human and no diseases involved. Or perhaps, Senator Kuehl and her fellow Democrat legislators visited http://www.RepairStemCells.org/StemCellTreatmentCenters.php for RSCI's comprehensive listing of stem cell treatment centers and doctors/researchers meeting the Institute's 'Standards of Excellence' and are collectively treating 100+ medical conditions."

Margolis had one last word for Gov. Schwarzenegger: "You defended your veto last week by claiming that California voters originally supported only embryonic stem cell research. That's just not true, Governor. They voted for Proposition 71, which specifically included 'adult stem cells'. Read the law, Governor!"

About RSCI:

The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.


'/>"/>
SOURCE Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
2. ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration
3. Phlo Affiliate Announces Significant Distribution Expansion In California
4. Californias International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
5. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
6. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
7. ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
8. Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage
9. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
10. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
11. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):